P. Gaburri

发表

HIGH PREVALENCE OF NON-ADHERENCE TO ULCERATIVE COLITIS THERAPY IN REMISSION: KNOWING THE PROBLEM TO PREVENT LOSS.

Fernanda Cristina Zimmermann Franco, Mirella Chrispim Cerqueira de Oliveira, P. Gaburri, 2022, Arquivos de gastroenterologia.

Internal Pancreatic Fistulas: Proposal of a Management Algorithm Based on a Case Series Analysis

P. Gaburri, J. Chebli, Aécio Flávio Meirelles de Souza, 2004, Journal of clinical gastroenterology.

Azathioprine in ulcerative colitis: Why, when, how and how long to use it

P. Gaburri, J. Chebli, T. Ribeiro, 2011 .

Impact of biological therapy on body composition of patients with Chron's disease.

P. Gaburri, C. Malaguti, T. Ribeiro, 2017, Revista da Associacao Medica Brasileira.

A Full Solid Diet as the Initial Meal in Mild Acute Pancreatitis is Safe and Result in a Shorter Length of Hospitalization: Results From a Prospective, Randomized, Controlled, Double-blind Clinical Trial

P. Gaburri, C. Gomes, L. Chebli, 2010, Journal of clinical gastroenterology.

The Impact of Spirituality and Religiosity on Mental Health and Quality of Life of Patients with Active Crohn’s Disease

P. Gaburri, C. Malaguti, G. Lucchetti, 2019, Journal of Religion and Health.

Prevalence and Pathogenesis of Duodenal Ulcer in Chronic Alcoholic Pancreatitis

P. Gaburri, J. Chebli, T. Ribeiro, 2002, Journal of clinical gastroenterology.

Impact of superimposed Clostridium difficile infection in Crohn’s or ulcerative colitis flares in the outpatient setting

P. Gaburri, L. Chebli, J. Chebli, 2018, International Journal of Colorectal Disease.

Benign intracranial hypertension during corticosteroid therapy for idiopathic ulcerative colitis: another indication for cyclosporine?

P. Gaburri, J. Chebli, G. Felga, 2004, Journal of clinical gastroenterology.

A guide to preparation of patients with inflammatory bowel diseases for anti-TNF-α therapy

P. Gaburri, J. Chebli, A. Damião, 2014, Medical science monitor : international medical journal of experimental and clinical research.

Long‐term results with azathioprine therapy in patients with corticosteroid‐dependent Crohn’s disease: Open‐label prospective study

P. Gaburri, J. Chebli, L. Chebli, 2007, Journal of gastroenterology and hepatology.

Azathioprine maintains long‐term steroid‐free remission through 3 years in patients with steroid‐dependent ulcerative colitis†

P. Gaburri, L. Chebli, J. Chebli, 2010, Inflammatory bowel diseases.

Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn’s disease patients

P. Gaburri, Maria Cristina Vasconcellos Furtado, L. C. Ribeiro, 2013, Medical science monitor : international medical journal of experimental and clinical research.

Early onset steroid-dependent ulcerative colitis is a predictor of azathioprine response: a longitudinal 12-month follow-up study.

P. Gaburri, L. Chebli, G. Felga, 2010, Medical science monitor : international medical journal of experimental and clinical research.

Spontaneous Bacterial Peritonitis: Is it Still a Life-Threatening Issue in Cirrhosis?

F. Pace, P. Gaburri, J. Chebli, 2016 .

Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication?

P. Gaburri, M. Kondo, T. C. Ribeiro, 2008, Therapeutics and clinical risk management.

Azathioprine is More Effective than Mesalazine at Preventing Recurrent Bowel Obstruction in Patients with Ileocecal Crohn’s Disease

P. Gaburri, Maria Cristina Vasconcellos Furtado, L. C. Ribeiro, 2014, Medical science monitor : international medical journal of experimental and clinical research.

Limp and Fever Leading to a Surprising Diagnosis.

P. Gaburri, L. Chebli, J. Chebli, 2019, The American journal of medicine.

Fatal evolution of systemic lupus erythematosus associated with Crohn's disease.

P. Gaburri, J. Chebli, F. Lucca, 2000, Arquivos de gastroenterologia.

RELATO DE CASOS / CASE REPORTS FATAL EVOLUTION OF SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATED WITH CROHN'S DISEASE

P. Gaburri, R. Carvalho-Filho, J. Chebli, 2000 .

[Intestinal parasitosis and hepatic cirrhosis].

P. Gaburri, M. H. Lopes, G. D. DE Paulo, 1997, Arquivos de gastroenterologia.

Oral refeeding in mild acute pancreatitis: an old challenge.

P. Gaburri, L. Chebli, J. Chebli, 2011, World journal of gastrointestinal pathophysiology.

Severe hypoproteinemia as a harbinger of Ménétrier's disease in autoimmune pancreatitis.

P. Gaburri, J. Chebli, T. Ribeiro, 2017, Revista da Associacao Medica Brasileira.

Small-Intestinal Bacterial Overgrowth is Associated With Concurrent Intestinal Inflammation But Not With Systemic Inflammation in Crohn’s Disease Patients

P. Gaburri, C. Malaguti, T. Ribeiro, 2018, Journal of clinical gastroenterology.

Enterovesical fistula in Crohn's disease

P. Gaburri, J. Chebli, Janine Radd Ferreira Pinto, 2004, The Lancet.

Preparing Patients With Inflammatory Bowel Diseases For Biological Therapies In Clinical Practice

P. Gaburri, J. Chebli, C. Malaguti, 2018 .

Intestinal ulcers due to drug-induced perinuclear anti-neutrophilic cytoplasmic antibody-positive vasculitis and antiphospholipid syndrome.

P. Gaburri, R. Assis, Lincoln Eduardo V V C Ferreira, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Infliximab-induced remission improves physical activity in patients with active Crohn's disease.

P. Gaburri, C. Malaguti, B. Pinheiro, 2020, Revista da Associacao Medica Brasileira.

[Epidemiology, clinical features and clinical course of Crohn's disease: a study of 60 cases].

P. Gaburri, M. H. Lopes, E. Froede, 1998, Arquivos de gastroenterologia.

Autoimmune pancreatitis and hepatitis: an uncommon association

P. Gaburri, J. Chebli, Lucila Vieira Quinet de Andrade, 2000, American Journal of Gastroenterology.

“idiopathic” acute pancreatitis due to biliary sludge: prevention of relapses by endoscopic biliary sphincterotomy in high-risk patients

P. Gaburri, J. Chebli, A. Ferrari, 2000, American Journal of Gastroenterology.

Choledocholithiasis

P. Gaburri, J. Chebli, José Maria Mendes Morais, 2005, The Lancet.

CUTANEOUS VASCULITIS WITH UNDETECTABLE CRYOGLOBULINEMIA IN CHRONIC HEPATITIS C

P. Gaburri, J. Chebli, E. Junior, 2004, Journal of gastroenterology and hepatology.

Azathioprine therapy in steroid-dependent patients with Crohn disease: results of a 10-year longitudinal follow-up study.

F. Pace, P. Gaburri, M. S. Ribeiro, 2009, Medical science monitor : international medical journal of experimental and clinical research.

Psychological distress in Brazilian Crohn's disease patients: screening, prevalence, and risk factors.

P. Gaburri, M. S. Ribeiro, L. Chebli, 2009, Medical science monitor : international medical journal of experimental and clinical research.

Splenic-portal- mesenteric thrombosis with splenic infarction as first presentation of essential thrombocytosis.

P. Gaburri, J. Chebli, Aécio Flávio Meirelles de Souza, 2004, Journal of Clinical Gastroenterology.

[Hyperlipemic pancreatitis: clinical course].

P. Gaburri, M. H. Lopes, G. D. DE Paulo, 1999, Arquivos de gastroenterologia.

Oral refeeding in patients with mild acute pancreatitis: Prevalence and risk factors of relapsing abdominal pain

P. Gaburri, J. Chebli, E. Junior, 2005, Journal of gastroenterology and hepatology.

Impact of biological therapy on body composition of patients with Chron's disease.

P. Gaburri, C. Malaguti, T. Ribeiro, 2017, Revista da Associacao Medica Brasileira.

Colonic ulcers in propylthiouracil induced vasculitis with secondary antiphospholipid syndrome

P. Gaburri, J. Chebli, E. Junior, 2005, Postgraduate Medical Journal.